Compare FDC LTD. with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. ORCHID PHARMA LTD FDC LTD./
ORCHID PHARMA LTD
 
P/E (TTM) x 17.5 -0.5 - View Chart
P/BV x 2.4 0.1 2,013.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 FDC LTD.   ORCHID PHARMA LTD
EQUITY SHARE DATA
    FDC LTD.
Mar-18
ORCHID PHARMA LTD
Sep-13
FDC LTD./
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs319194 164.4%   
Low Rs16435 468.6%   
Sales per share (Unadj.) Rs61.6276.5 22.3%  
Earnings per share (Unadj.) Rs9.9-79.2 -12.6%  
Cash flow per share (Unadj.) Rs12.0-43.5 -27.5%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs73.253.9 135.7%  
Shares outstanding (eoy) m174.4070.45 247.6%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x3.90.4 945.9%   
Avg P/E ratio x24.3-1.4 -1,679.2%  
P/CF ratio (eoy) x20.2-2.6 -766.0%  
Price / Book Value ratio x3.32.1 155.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m42,1188,067 522.1%   
No. of employees `0005.52.8 197.5%   
Total wages/salary Rs m2,1672,527 85.7%   
Avg. sales/employee Rs Th1,943.76,956.1 27.9%   
Avg. wages/employee Rs Th391.7902.5 43.4%   
Avg. net profit/employee Rs Th313.7-1,993.0 -15.7%   
INCOME DATA
Net Sales Rs m10,75119,477 55.2%  
Other income Rs m510407 125.1%   
Total revenues Rs m11,26019,884 56.6%   
Gross profit Rs m2,2671,103 205.6%  
Depreciation Rs m3512,519 13.9%   
Interest Rs m145,227 0.3%   
Profit before tax Rs m2,411-6,236 -38.7%   
Minority Interest Rs m-520 -24.4%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m671-125 -536.1%   
Profit after tax Rs m1,735-5,580 -31.1%  
Gross profit margin %21.15.7 372.5%  
Effective tax rate %27.82.0 1,386.6%   
Net profit margin %16.1-28.7 -56.3%  
BALANCE SHEET DATA
Current assets Rs m7,21311,014 65.5%   
Current liabilities Rs m2,10432,060 6.6%   
Net working cap to sales %47.5-108.1 -44.0%  
Current ratio x3.40.3 998.0%  
Inventory Days Days5495 57.4%  
Debtors Days Days2834 82.6%  
Net fixed assets Rs m6,86529,440 23.3%   
Share capital Rs m175705 24.9%   
"Free" reserves Rs m12,5862,043 616.2%   
Net worth Rs m12,7613,800 335.8%   
Long term debt Rs m69,018 0.1%   
Total assets Rs m15,04146,510 32.3%  
Interest coverage x173.2-0.2 -89,696.2%   
Debt to equity ratio x02.4 0.0%  
Sales to assets ratio x0.70.4 170.7%   
Return on assets %11.6-0.8 -1,530.0%  
Return on equity %13.6-146.9 -9.3%  
Return on capital %19.0-3.7 -507.6%  
Exports to sales %12.337.9 32.6%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs m1,3277,378 18.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m1,8897,513 25.1%   
Fx outflow Rs m05,649 0.0%   
Net fx Rs m1,8891,865 101.3%   
CASH FLOW
From Operations Rs m1,4981,682 89.1%  
From Investments Rs m201-9,860 -2.0%  
From Financial Activity Rs m-1,6946,644 -25.5%  
Net Cashflow Rs m10-1,535 -0.7%  

Share Holding

Indian Promoters % 68.9 32.3 213.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 4.6 102.2%  
FIIs % 7.5 3.3 227.3%  
ADR/GDR % 0.0 4.6 -  
Free float % 19.0 55.3 34.4%  
Shareholders   23,730 84,811 28.0%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   CADILA HEALTHCARE  J.B.CHEMICALS  PROCTER & GAMBLE HEALTH  DISHMAN PHARMA  FULFORD INDIA  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

FDC LTD. Announces Quarterly Results (3QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Feb 15, 2019 | Updated on Feb 15, 2019

For the quarter ended December 2018, FDC LTD. has posted a net profit of Rs 437 m (up 2.5% YoY). Sales on the other hand came in at Rs 3 bn (up 1.4% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 20, 2019 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS